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Introduction: Mesenchymal stromal cells (MSC) have well defined immunomodulatory properties including the
suppression of lymphocyte proliferation and inhibition of dendritic cell (DC) maturation involving both cell contact
and soluble factors. These properties have made MSC attractive candidates for cellular therapy. However, the
mechanism underlying these characteristics remains unclear. This study sought to investigate the mechanisms by
which MSC induce a regulatory environment.
Method: Allogeneic bone marrow mesenchymal stromal cells were cultured with T cells or dendritic cells in the
presence or absence of gamma secretase inhibitor to block Notch receptor signalling. T cells and dendritic cells
were examined by flow cytometry for changes in phenotype marker expression. Stable knock down MSC were
generated to examine the influence of Jagged 1 signalling by MSC. Both wildtype and knockdown MSC were
subsequently used in vivo in an animal model of allergic airway inflammation.
Results: The Notch ligand Jagged-1 was demonstrated to be involved in MSC expansion of regulatory T cells (Treg).
Additionally, MSC-induced a functional semi-mature DC phenotype, which further required Notch signalling for the
expansion of Treg. MSC, but not Jagged-1 knock down MSC, reduced pathology in a mouse model of allergic
airway inflammation. Protection mediated by MSC was associated with enhanced Treg in the lung and significantly
increased production of interleukin (IL)-10 in splenocytes re-stimulated with allergen. Significantly less Treg and
IL-10 was observed in mice treated with Jagged-1 knock down MSC.
Conclusions: The current study suggests that MSC-mediated immune modulation involves the education and
expansion of regulatory immune cells in a Jagged-1 dependent manner and provides the first report of the importance
of Jagged-1 signalling in MSC protection against inflammation in vivo.Introduction
Adult mesenchymal stromal (stem) cells (MSC) are mul-
tipotent cells that have the ability to differentiate into a
number of lineages, including bone, fat and cartilage
[1,2]. Primarily, MSC are found in the bone marrow
where they provide support for haematopoietic stem
cells [3], but they have also been isolated from other tis-
sues [4]. Advances in MSC isolation, culture and differ-
entiation have highlighted MSC as pivotal cells in* Correspondence: karen.english@nuim.ie
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unless otherwise stated.regenerative medicine. However, it is becoming apparent
that MSC therapy is based less on in situ differentiation
abilities and more on paracrine or trophic factors [5].
MSC can home to sites of injury and induce repair
through the release of trophic factors, such as cytokines
[6]. One of the major attractions for using MSC as a
therapeutic agent lies in the fact that MSC possess an
array of immunosuppressive capabilities and can be used
in an allogeneic setting. MSC avoid allogeneic rejection
through suppressive actions on both the innate and
adaptive immune responses [7,8]. However, the precise
immunosuppressive signals employed by MSC are not
well understood.his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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cells (tDC) or regulatory T cells (Treg), assist in the
maintenance of peripheral tolerance through the active
suppression of effector T cell populations, preventing
autoimmunity through the activation of self-reactive
lymphocytes [9]. This can occur directly through cell-
contact mediated suppression of self-reactive effector
CD4+ T cells by Treg, (infectious tolerance), through the
deletion (killing) of effector cells or through the creation
of an immunosuppressive environment via the release of
regulatory cytokines (bystander suppression) [10,11]. tDC
populations typically exhibit an immature or ‘semi-mature’
phenotype, which is defined by low levels of major histo-
compatibility complex (MHC) and co-stimulatory marker
expression, decreased IL12p70 and increased IL-10 pro-
duction [9,12]. The two main categories of Treg are nat-
ural Treg, which develop in the thymus and enter the
periphery, and inducible Treg that are induced in the per-
iphery from naïve T cells and aid in the maintenance of
tolerance [13]. Both types of Treg can achieve suppression
through the production of soluble factors, namely IL-10
and transforming growth factor beta (TGFβ) [14].
Subpopulations of DC in the periphery can induce
Treg from naïve CD4+ T cells [15,16]. These tDC can
present antigen to antigen-specific T cells, but fail to de-
liver adequate co-stimulation for effector T cell prolifera-
tion [9]. A key factor involved in the induction of these
DC is IL-10, as the presence of this cytokine can reduce
MHC class II expression and IL-12 production [12,17].
tDC expand CD4+ CD25+ Treg from CD4+ CD25− pre-
cursors [18], leading to the expansion of antigen-specific
Treg which contribute to the prevention of autoimmun-
ity [9,19].
MSC can indirectly induce Treg via the modulation of
DC phenotypes [20-23] or directly in the absence of DC
[24]. English et al. have shown that human MSC expand
Treg expressing FoxP3 cells through the release of sol-
uble factors PGE2 and TGF-β1, but this study also indi-
cated a role for a cell contact signal [25]. MSC-mediated
inhibition of T cell proliferation occurs under proinflam-
matory conditions and stimulation with IFN-γ induces
the production of IDO by MSC [26], now known to play
an important role in MSC suppression of T cell prolifer-
ation [27,28]. In addition to PGE2 and TGF-β1, a re-
quirement for HLA-G5 has also been demonstrated in
MSC expansion of Treg, an effect involving IL-10 and
cell contact [29]. MSC-induced Treg are functional and
play an important role in vivo. In an animal model of al-
lergic asthma, MSC were shown to ameliorate pathology
and inhibit inflammation through a Treg dependent
mechanism [30].
Notch signalling is a well conserved pathway involved
in cell fate decisions during development, cell prolifera-
tion, differentiation and apoptosis [31,32]. Interactionsbetween Notch receptors and ligands are crucial in the
crosstalk between cells of the immune system and their
surrounding microenvironment [32]. Notch receptors
and ligands are expressed on numerous immune cells in-
cluding DC and T cells, and the presence of bacterial
products, such as lipopolysaccharide (LPS) elevates the
expression of Notch ligands on DC [33]. Cheng et al.
have shown that the Notch ligand Jagged-1, on bone
marrow-derived stromal cells, stimulated the accumula-
tion of DC precursors, preventing their transition to ter-
minally differentiated DC. Following exit of the bone
marrow, the expression of Delta like ligand-1 on spleen
stroma permits full differentiation of DC [34]. In terms
of T cell activation and proliferation, Notch signalling
plays a key role. Rutz et al. demonstrated that Delta-like
ligand-1 and Jagged-1 induced partial or complete inhib-
ition of T cell activation, while the expression of Delta
like ligand-4 enhanced T cell proliferation [35]. Further-
more, both murine and human naïve CD4+ T cells have
been differentiated into FoxP3 expressing Treg following
TGF-β1 signalling through the Notch pathway [36,37].
Combined, these data provide significant evidence for
the involvement of the Notch signalling pathway in the
crosstalk between innate and adaptive immune cells and
highlights the potential importance of this pathway as a
candidate for the contact signal involved in MSC modu-
lation of adaptive immune responses.
This study sought to investigate the importance of the
Notch signalling pathway in MSC induction of regula-
tory DC and CD4+ T cells. The Notch signalling inhibi-
tor, gamma secretase (GSI), was used to determine the
role of this pathway in MSC-mediated immune regula-
tion using a co-culture system, involving murine MSC,
DC or CD4+ T cells. Jagged-1, a Notch ligand, was
knocked down in murine MSC using shRNA technology.
Interestingly, the expression of Jagged-1 was required for
the expansion of CD4+ CD25+ FoxP3+ Treg by allogen-
eic MSC in vitro. Allogeneic MSC were capable of dis-
rupting the maturation of DC, inducing a semi-mature
tolerogenic DC phenotype. Additionally, these tolero-
genic DC induced by MSC were capable of inducing
Treg from a population of CD4+ CD25− FoxP3− cells.
These data confirmed that allogeneic MSC are capable
of regulatory cell expansion in vitro and that this process
requires Jagged-1 signalling. Utilising a mouse model of
allergic airway inflammation, this study demonstrated
the important role played by Notch signalling and spe-
cifically MSC expression of Jagged-1 in MSC-mediated
protection against inflammation in vivo. MSC, but not
Jagged-1 knock down MSC, reduced allergen driven air-
way pathology. The abrogation of protection observed
with Jagged-1 knock down MSC was associated with de-
creased Treg in the lungs and reduced IL-10 production
in the spleen. Importantly, this study demonstrates a role
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pathway in the development of a regulatory environment
by MSC both in vitro and in vivo.
Materials and methods
Animals
Six- to eight-week old female BALB/c, C57BL/6 (Harlan,
BiMA, Chester, Oxon, UK), BALB/c-Tg (DO11.10)10Loh/J
or eGFP-FoxP3 (The Jackson Laboratories, Bar Harbour,
Maine, USA) were used for cell based experiments under
the guidelines of the Irish Department of Health and the
approval of the research ethics committee of the National
University of Ireland Maynooth. Allergen sensitization was
carried out as previously described [38] using eight- to
twelve-week old female BALB/c mice. Mice were main-
tained according to the regulations of the Irish Department
of Health, and the institutional research ethics committee.
Mice were sensitized by intra-peritoneal injection of 33 μg/
mouse ovalbumin (OVA) emulsified in aluminium hydrox-
ide (AlumImject™) (Pierce, Rockford, IL, USA) on days 0, 7
and 14. Mice were challenged intra-nasally with OVA
(50 μg/mouse) or sterile PBS on days 14, 25, 26 and 27.
BALB/c derived MSC or Jagged-1 knock down MSC (gen-
erated as described below) were administered intravenously
in sterile PBS (0.5 × 106/mouse) on days 7 and 14.
Histopathology
On day 28, lungs were harvested, fixed and paraffin embed-
ded followed by sectioning and staining with haematoxylin/
eosin (H & E). For analysis of airway pathology, at least five
fields of view were examined in five sections from five dif-
ferent mice per group. Pathology was scored using a semi-
quantitative scoring system as mild, moderate or severe.
Lung digestion and preparation of single cell suspension
for analysis of Foxp3
On day 19, lungs were harvested and homogenised using a
tissue homogeniser and centrifuged at 1,500 RPM for five
minutes. The tissue pellet was then digested with 100 U/ml
collagenase (Sigma Aldrich, Arklow, Ireland) and 20 U/ml
DNase (Roche, Dublin, Ireland) in 1 ml PBS at 37°C for
one hour. The tissue was then passed through a 70 μm
pore cell strainer and resuspended in 25 ml RPMI and
overlayed on 15 ml lymphocyte separation media (PAA,
London, UK). A density gradient centrifugation step was
then performed at 2,400 RPM for 25 minutes without the
brake at room temperature (RT). The buffy layer consisting
of lymphocytes was removed for counting and staining for
Foxp3 as described below.
Measurement of IL-10 in splenocytes re-stimulated with
ovalbumin
Spleens were harvested on day 19 and a single cell suspen-
sion was prepared by dissociating spleens and passingthrough a 70 μm pore cell strainer before centrifugation
and subsequent red blood cell lysis. Splenocytes were
counted and cultured at 1 × 105/well in triplicate in
complete RPMI in a 96-well round bottomed plate. Spleen
cells were re-stimulated with OVA (200 μg/ml) for
48 hours. Supernatants were harvested and analysed in
triplicate for IL-10 by ELISA (Peprotech, London, UK)
according to the manufacturer’s instructions.
Isolation and characterisation of bone marrow derived
mesenchymal stem cells
Murine MSC were isolated from the bone marrow of
BALB/c or C57BL/6 mice as previously described [28].
Briefly, following the isolation of bone marrow, MSC
were cultured in complete RPMI, supplemented with
10% (v/v) heat inactivated fetal bovine serum (FBS)
(Invitrogen-Gibco, Paisley, Scotland), 10% (v/v) equine
serum (Hyclone Laboratories, Logan, UT, USA), 1% (v/v)
penicillin/streptomycin (Invitrogen-Gibco,), and 1% (v/v)
L-glutamine (Invitrogen-Gibco) for 28 days, replacing
with fresh media every three to four days. At passage 2,
MSC were expanded in complete alpha MEM supple-
mented with 10% (v/v) heat inactivated FBS, 10% (v/v)
equine serum, 1% (v/v) penicillin/streptomycin and 1%
(v/v) L-glutamine. MSC were analysed for the expres-
sion of a variety of fluorescein isothiocyanate (FITC)
or phycoerythrin (PE) conjugated surface markers in-
cluding Sca-1, MHC class I, MHC class II, CD11b,
CD11c, CD34, CD44, CD45, CD80, CD86, CD90,
CD105, CD106 and CD117 (eBiosciences, San Diego,
CA, USA) by flow cytometry (BD FACS Calibur and
CellQuest software) at every passage (Additional file 1:
Figure S1A). The ability of MSC to suppress allogeneic
and mitogen-driven proliferation was also assessed at
each passage (Additional file 1: Figure S1B). The differ-
entiation capacity of MSC following the addition of dif-
ferentiation media [25] into osteocytes, adipocytes and
chondrocytes were analysed at every passage (Additional
file 1: Figure S1C,D). MSC used in these studies expressed
MHC class I, Sca-1, CD44 and CD106 and differentiated
into all three lineages mentioned above. MSC were used
between passage three to ten.
shRNA
Five Jagged-1 short hairpin RNA (shRNA) plasmids were
expressed in the lentiviral vector pGIPZ (Open Biosystems-
Thermo, Dublin, Ireland). Jagged-1 plasmids were trans-
fected into HEK293t cells along with the packaging plasmid
Trans-Lentiviral packaging mix (Open Biosystems, (Fisher
Scientific), Dublin, Ireland) using Gene Juice (Merck, Millipore,
Darmstadt, Germany). HEK293t cells were cultured in high
glucose (D)MEM (Sigma Aldrich, Arklow, Ireland) supple-
mented with 10% (v/v) heat inactivated FBS, 1% (v/v)
penicillin/streptomycin (Invitrogen, (Life Technologies),
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ing transfection they were cultured in serum free (D)
MEM without antibiotics. After 24 hours transfection,
they were switched to 30% FBS. The supernantant con-
taining the Jagged-1 shRNA lentivirus was collected
48 hours after transfection. BALB/c MSC were trans-
duced with the viral medium for 72 hours followed by
positive selection using 4 μg/ml puromycin. shRNA
knock down cells were characterised as above and expres-
sion of Jagged-1 was examined by real-time PCR to ensure
stable knock down following sub-cloning (Additional files
2 and 3: Figures S2 and S3).
Co-culture experiments: MSC, DC and T cells
Immature DC were isolated from the bone marrow of
BALB/c or C57BL/6 mice and cultured in complete RPMI
(containing 10% (v/v) heat inactivated FBS, 1% (v/v) penicillin/
streptomycin and 1% (v/v) L-glutamine) supplemented with
20 ng/ml of recombinant murine Granulocyte monocyte-
colony stimulating factor (GM-CSF), cell culture medium
was replenished on day 3 and 6. Immature DC were har-
vested on day 8 and matured (0.5 × 106/ml) in the presence
of LPS (100 ng/ml) (Sigma-Aldrich) for 48 hours in the
presence or absence of bone marrow derived MSC (1.5 ×
105/ml) in a six-well plate (Final Ratio 3:1 DC:MSC).
The expression of maturation markers, MHC II and CD86
was analysed by flow cytometry on DC using BD FACS
Calibur and CellQuest software or BD Accuri C6 and
corresponding software (Additional file 4: Figure S4A,B).
CD4+ T cell proliferation
Immature BALB/c DC (0.5 × 106/ml) were pulsed with
OVA (20 μg/ml) (Sigma-Aldrich) in the presence or
absence of allogeneic MSC (1.5 × 105/ml) or GSI (1 μM)
for 24 hours in a six-well plate (Final Ratio 3:1 DC:MSC).
DC were harvested from adherent MSC via gentle aspir-
ation and further cultured with naïve OVA-specific I-Ad
restricted CD4+ T cells (4 × 105/ml) (Final Ratio 4:1 T:DC)
isolated from DO11.10 murine spleens using MagCellect
(R & D Systems, Abingdon, UK) for 72 hours. Prolifera-
tion was analysed using thymidine (5 μCi/ml) incorpor-
ation quantified as mean counts per minute (± SE) by
liquid scintillation (1,450 Microbeta Liquid Scintillation
counter, Wallac-Perkin Elmer, Dublin, Ireland).
FoxP3 detection
C57BL/6 T cells were isolated by positive selection for
CD4 using magnetic-activated cell sorting (MACS)
beads (Miltenyi Biotech, Surrey, UK) or by cell sorting
for CD4+CD25−FoxP3− cells. Subsequently, sorted T
cells (1 × 106/ml) were cultured in the presence or ab-
sence of MSC or Jagged-1 knock down MSC (3.3 ×
105/ml) or GSI (1 μM) for 72 hours in a six-well plate
(Final Ratio 1:3 MSC:T cells). CD4+ regulatory T cellswere detected by expression of GFP-FoxP3 and CD25
(eBioscience) by flow cytometry. Preparation for Foxp3
detection in separated cells and ex vivo tissues (lungs)
was performed using a Foxp3 Staining Buffer Set
(eBioscience) according to the manufacturer’s instructions.
Statistics
Statistical analysis was performed using GraphPad
Prism™ software (GraphPad, San Diego, CA, USA). The
student’s paired t-test was used when statistical analysis
was required between two experimental groups. One
way analysis of variance (ANOVA) was used to test for
statistical significance of differences when multiple ex-
perimental groups were compared. Data are presented
as the ± standard error of the mean (SEM). P-values of
P <0.05 (*), P <0.01 (**) or P <0.001 (***) were considered
statistically significant.
Results
Notch signalling is required for MSC expansion of
regulatory T cells
Previous data published by our group demonstrated that
MSC are capable of expanding Treg both in vitro, using
a co-culture system to establish the importance of sol-
uble factors released by MSC, and in vivo, using an OVA
induced model of allergic asthma [25,30]. Neither study
however, determined whether MSC were expanding the
native Treg population or inducing Treg from naïve T
cells. To investigate this, CD4+ T cells were isolated
from an eGFP-FoxP3 knock-in mouse using separation
beads and sorted for two populations of cells, CD4+
CD25+ FoxP3-GPF+ or CD4+ CD25− FoxP3-GFP−. In
these mice, the FoxP3 transcription factor is co-
expressed with eGFP, allowing for specific detection of
FoxP3 solely from the spleen cells isolated from these
mice. This is an advantage when working with MSC as
previous studies have demonstrated expression of FoxP3
in MSC; however, this was not replicated in our hands
(data not shown). When the CD25− FoxP3− T cells were
co-cultured with allogeneic MSC, GFP-FoxP3 was not
detected, suggesting that MSC did not induce the expres-
sion of FoxP3 on CD4+ CD25− T cells in vitro (Figure 1A).
However, following co-culture of MSC with CD4+ CD25+
FoxP3+ T cells for 72 hours, the expression of both CD25
and FoxP3 was increased, indicating that MSC were
involved in the expansion of existing FoxP3+ Treg
(Figure 1A,B).
To investigate the role of Notch signalling in MSC ex-
pansion of CD4+CD25+FoxP3+ Treg, CD4+ T cells were
co-cultured with MSC in the presence or absence of a
Notch signalling inhibitor (GSI). MSC cultured with
purified CD4+ T cells supported the expansion of
CD4+CD25+FoxP3+ T cells. However, in the presence of
GSI, the percentage of cells expressing both CD25 and
Figure 1 (See legend on next page.)
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Figure 1 MSC promote the expansion of regulatory T cells in a Notch dependent manner, specifically through Jagged 1 signalling. T
cells from eGFP-FoxP3 transgenic mice were isolated by magnetic bead isolation (CD4) or cell sorting (CD4+ CD25− FoxP3−), and subsequently
cultured with or without MSC for 72 hours and examined for CD25 and FoxP3-GFP expression by flow cytometry. Culture of CD4+ CD25− FoxP3− cells
cultured with MSC did not result in an increase in regulatory T cells whereas co-culture of CD4+ T cells with MSC resulted in expansion of the existing
regulatory population (A,B). MSC significantly increased the expansion of Treg cells, compared to CD4 cells cultured alone (***, P <0.001), bar chart
displaying n = 7 (B). To examine the role of Notch, CD4+ T cells were cultured with MSC in the presence or absence of GSI (1 μM) or vehicle control
DMSO and examined for CD25 and GFP expression by flow cytometry (C). CD4+ T cells were cultured with wild type MSC or Jagged-1 knockdown
MSC for 72 hours and then examined for CD25 and FoxP3-GFP expression by flow cytometry (D). Counting beads were used to determine the number
of cells expressing both CD25 and FoxP3 (E). Data are representative of three studies. DMSO, dimethyl sulfoxide; GSI, gamma secretase inhibitor; MSC,
mesenchymal stromal cells; Treg, regulatory T cells.
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DMSO, had no effect on the expansion of Treg. These
data suggested that MSC expansion of CD4+CD25+FoxP3
+ Treg required functional signalling through the Notch
pathway.
MSC expressed high levels of Notch-2, Jagged-1 and
Delta like ligand-1 and lower levels of Notch-1 and
Jagged-2 (Additional file 2: Figure S2). Previously pub-
lished data on the Notch ligand Jagged-1 suggested a
role for this ligand in the induction of Treg. Overexpres-
sion studies showed that activation of the Notch path-
way on CD4+ T cells by Jagged-1 resulted in increased
expression of CD25 and FoxP3 [39]. Given the import-
ant role for Jagged-1 in Treg induction and the high
expression by MSC, Jagged-1 was chosen for targeted in-
hibition studies. Jagged-1 expression on MSC was stably
knocked down using lentiviral shRNA (Additional file 2:
Figure S2). Jagged-1 knock down MSC were used in co-
culture with CD4+ T cells to determine the role for
Jagged-1 in MSC driven expansion of Treg. CD4+ T cells
were isolated from eGFP-FoxP3 mice and co-cultured
with allogeneic wild-type MSC, or Jagged-1 knock down
MSC (Figure 1D,E). In the absence of MSC, the CD4+ T
cell population contained low levels of FoxP3+ cells after
three days. Wild-type MSC supported the expansion of
CD4+CD25+ FoxP3+ T cells whereas Jagged-1 knock
down MSC were unable to expand CD4+FoxP3+CD25+
Treg (Figure 1D,E). These data demonstrated that the
ability of MSC to expand Treg required Jagged-1 signal-
ling. A caveat to interpreting these results lies in the
non-silencing control. This plasmid is typically used
where an empty vector is packaged into viral units and
the MSC are transduced to ensure there are no uninten-
tional side effects to the viral transduction. In the case
of MSC, the non-silencing control delivered by means of
a lentivirus may stimulate the TLR3 receptor which is
responsible for detecting viral double stranded DNA.
TLR3 stimulation on MSC results in the down regula-
tion of Jagged-1 at both the mRNA and protein level
[40]; for this reason the non-silencing control could not
be used as a valid control for lentiviral transduction in
this case. In an effort to overcome this, reverse tran-
scriptase PCR was also performed on lentiviral treatedMSC to ensure that knock down of Jagged-1 did not inter-
fere with expression of the other Notch ligands. Additional
file 2: Figure S2D demonstrates that Delta like ligand-1
(Dll1) expression is not affected in both Jagged-1 KD MSC
and non-silencing control MSC. These results confirm that
treatment of MSC with Jagged-1 shRNA results in signifi-
cantly reduced expression of Jagged-1 at both an mRNA
level and a protein level. Although non-silencing control
cells also showed reduced expression of Jagged-1, there was
no change in the expression of another Notch ligand, Dll1.
Taken together it can be concluded from these results
that any effects seen from shRNA treated MSC were a
consequence of eliminating Jagged-1 signalling.
MSC induction of functional tolerogenic dendritic cells
required Notch signaling
Murine MSC suppress the maturation, migration and
antigen presentation of DC in vitro ([21] and Additional
file 4: Figure S4A,B) leading to the generation of a tDC
population. Although wild-type MSC prevented DC
antigen presentation, knocking down Jagged-1 in MSC
partially reversed this effect (Additional file 4: Figure
S4C). The importance of Notch signalling in allogeneic
MSC induction of tDC was investigated using a co-
culture system. BALB/c DC were pulsed with OVA in
the presence or absence of C57BL/6 MSC. DC were then
harvested by gentle aspiration from adherent MSC and
cultured with OVA specific DO11.10 CD4+ T cells. DC
pulsed with OVA that had not encountered MSC, were
capable of supporting DO11.10 CD4+ T cell proliferation
(Figure 2). In contrast, DC pulsed with OVA in the pres-
ence of MSC were significantly less proficient in sup-
porting CD4+ T cell proliferation (Figure 2) indicating
that MSC encounter impairs DC capacity to promote T
cell proliferation.
The role of Notch signalling in this interaction was
also examined using the two stage assay. Following co-
culture with MSC and GSI, OVA pulsed DC were re-
purified by gentle aspiration and re-cultured with
DO11.10 CD4+ T cells. Interestingly, by blocking Notch
signalling through the addition of GSI (but not the vehicle
control, DMSO), MSC were no longer able to induce
functional tDC, as indicated by a significantly increased
Figure 2 Notch is required for the induction of functionally
tolerogenic DC by MSC. A two-stage proliferation assay was carried
out. Stage one: BALB/c DC (0.5 × 106/ml) were pulsed with OVA
(20 μg/ml) in the presence or absence of allogeneic MSC (1.5 × 105/ml),
GSI (1 μM) or DMSO (vehicle control) for 24 hours. Stage two: DC were
harvested and placed into a second proliferation assay with DO11.10
CD4+ T cells (1:4, 1 × 105 DC: 4 × 105/ml T cells for 72 hours. Proliferation
was analysed using thymidine (5 μCi/ml) incorporation quantified as
mean counts per minute (± SEM) by liquid scintillation. Data represent
three studies (*, P < 0.05; **, P < 0.01). DC, dendritic cells; DMSO,
dimethyl sulfoxide; GSI, gamma secretase inhibitor; MSC, mesenchymal
stem cells; OVA, ovalbumin; SEM, standard error of the mean.
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addition, the proliferation of OVA-specific T cells in-
creases over the baseline when DC were primed in the
presence of MSC and GSI. This suggests that removing
the suppressive capability of MSC during DC priming, un-
covers an allogeneic stimulus. These data confirmed that
Notch signalling was required for the induction of a func-
tional tDC population by MSC in vitro.
MSC educated tolerogenic dendritic cells induced
regulatory T cells in vitro
Induction of Treg could account for the inhibition ob-
served in the proliferation assay. Therefore, the influence
of MSC on DC driven induction of Treg was studied.
C57BL/6 DC were co-cultured with allogeneic MSC in
the presence or absence of LPS. TLR stimulation of
MSC has been shown to alter both the expression of im-
mune modulatory factors and the immune suppressive
function of MSC [40-42]. However, these findings are
conflicting, with some studies showing that TLR activa-
tion reduces, or others that it enhances, MSC immune
suppressive effects. In addition, these studies examining
LPS stimulation of MSC focus on MSC effects on T cell
proliferation. After 48 hours, DC were recovered by gen-
tle aspiration from adherent MSC and subsequentlycultured with sorted FoxP3-eGFP− CD25− T cells. DC
matured with LPS (mDC) induced two fold more FoxP3+
Tregs than immature DC (iDC). In line with this, stud-
ies have shown that LPS-matured DC secrete anti-
inflammatory cytokines (IL-10) and promote the induction
of Treg [43-45]. Interestingly, DC that had previously
been co-cultured with MSC and expressed MHC
ClassIIlow and CD86low cells markers (tDC) induced
greater numbers of FoxP3+ Treg (approximately seven
fold more than iDC). These data provided strong evidence
to suggest that MSC educated DC promote a regulatory
environment (Figure 3).
MSC therapy, but not Jagged-1 knock-down MSC therapy,
reduced allergen-driven airway pathology and increased
Treg in the lungs in an animal model
Previously, we demonstrated the capacity for MSC to
prevent allergic airway inflammation and discovered a
key role for Treg in this setting [30]. A standard murine
model of allergic pathology was utilised to investigate
the importance of Jagged-1 signalling in MSC protection
against allergen-driven airway pathology. In line with
our previous findings, MSC therapy reduced pathology
and decreased peribronchial inflammation (Figure 4A) in
comparison to OVA-sensitized mice without MSC treat-
ment (Figure 4A). In contrast, treatment with Jagged-1
knock down MSC failed to prevent peribronchial inflam-
mation and bronchial epithelial hypertrophy (Figure 4A).
Given that MSC protection in this model of allergic airway
inflammation has been shown to require Treg, the pres-
ence of Treg in the lungs of these mice was examined
ex vivo using flow cytometry. Notably, a significant in-
crease in the proportion of Foxp3+ CD4+ T cells was ob-
served in the lungs of MSC treated compared to untreated
OVA-sensitized mice (Figure 4B) consistent with previous
observations [30,46]. However, there was no significant in-
crease in Foxp3+ CD4+ T cells in lungs from Jagged-1 KD
MSC treated OVA-sensitized mice (Figure 4B,C).
MSC may promote immune suppression through en-
hancing secretion of anti-inflammatory cytokines such
as IL-10. To test this hypothesis, spleen cells from OVA
sensitized and MSC treated or untreated mice were
harvested and re-stimulated with OVA ex vivo. IL-10
production by spleen cells post OVA re-stimulation
was measured by ELISA. Enhanced IL-10 levels were
observed in spleen cell supernatants from MSC treated
mice and this was significantly reduced in the Jagged-1
knock down MSC treated group (Figure 4D). Although
previous studies have demonstrated the capacity for
MSC to enhance macrophage derived IL-10 in vivo
[47], the increase in the proportion of Treg and pro-
duction of IL-10 by spleen cells suggests that IL-10
was produced by Treg in this case. These data suggest
that Jagged-1 is involved in MSC promotion of Treg
Figure 3 MSC educated tolerogenic DC induce regulatory T cells. C57BL/6 DC were cultured in the absence (immature DC) or presence
(mature DC) of LPS without or with MSC (tolerogenic DC), and harvested from adherent MSC via gentle aspiration after 48 hours. These DC cells
were washed and subsequently cultured with sorted CD4+CD25−FoxP3− T cells at a ratio of 1:4 DC to T cell, for 72 hours. T cells were gated on
CD3 to discriminate them from the DC. Expression of CD25 and FoxP3-GFP was examined by flow cytometry following co-culture with immature
DC (A), mature DC (B) or tolerogenic DC (C). MHCIIlow CD86low tolerogenic DC significantly increased the induction of Tregs compared to immature
DC or mature DC (**, P <0.01) (D). Data in figures A, B and C are representative flow cytometry plots while figure D shows statistics from three studies.
DC, dendritic cells; LPS, lipopolysaccharide; MHC, major histocompatibility complex; MSC, mesenchymal stromal cells.
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and in the secondary lymphoid organs, respectively.
Moreover, this study combined with our previous data
[30] supports the idea that MSC require Jagged-1 to
promote the expansion of functional Treg in vivo,
which have previously been demonstrated to be re-
quired in MSC protection in allergic airway-induced
inflammation [30].
Discussion
The present study sought to demonstrate that allogeneic
murine bone marrow derived MSC modulate a regula-
tory environment through the Notch signalling pathway.
Global inhibition of Notch signalling using GSI and tar-
geted inhibition of Jagged-1 signalling through shRNA
knock down resulted in abrogation of MSC regulatory T
cell expansion. While DC that encountered MSC displayed
a ‘semi-mature’ phenotype capable of inhibiting antigenspecific T cell proliferation, these MSC-induced DC were
also capable of Treg expansion. Although the expansion
of a Treg population is a known consequence of tDC and
T cell co-culture, to our knowledge this is the first time
tDC generated in the presence of MSC have been shown
to induce Treg from a CD4+Foxp3− population.
Interactions between Notch receptors and ligands play
a crucial role in the cross talk between cells of the im-
mune system and their surrounding microenvironment
[32]. The expression of Notch receptors and ligands are
important in stem cell maintenance, cell proliferation,
differentiation, apoptosis and induction of peripheral tol-
erance [31,32,48]. English et al. previously demonstrated
a role for both soluble factors, PGE-2 and TGF-β1, and
an unknown cell contact signal required for MSC expan-
sion of Treg in vitro [25]. Recently Kavanagh et al. ex-
plored the significance of MSC expansion of Treg in an
in vivo model of allergic airway inflammation. Using an
Figure 4 Jagged 1 knockdown abrogates MSC protection in an OVA driven mouse model of allergic airway inflammation.
Representative images of H & E staining (magnification x100 (left column) and x400 (right column)) from OVA sensitized mice at day 28. MSC, Jag
1 KD MSC or PBS was administered intravenously on day 7 and day 14 (A). A single cell suspension was isolated from the lung at day 19 and
analysed by flow cytometry. CD4+ cells were gated and examined for FoxP3 expression (B), summarised as % positive CD4+FoxP3+ cells (C). Spleen
cells isolated at day 19 were cultured and re-stimulated with 200 μg/ml OVA for 48 hours. Supernatant was collected and IL-10 expression determined
by ELISA (D) n = 5. (*, P <0.05; **, P <0.01). KD, knockdown; MSC, mesenchymal stromal cells; OVA, ovalbumin.
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were shown to reduce lung pathology and cell infiltra-
tion through expansion of a Treg cell population, an ef-
fect that was abrogated when Treg populations were
depleted [30]. MSC inability to induce Treg (in this sys-
tem) from a FoxP3− population infers a role in the expan-
sion of Treg rather than the education of naïve T cells.
It is well documented that MSC are capable of expand-
ing a Treg population, both in vitro and in vivo. While
many studies describe the importance of soluble media-
tors, less is known about the cell contact signal required
[25,49,50]. Numerous studies have suggested a role for
Notch signalling in the induction of Treg in general
[39,51-53]. Yvon et al. demonstrated that antigen pre-
senting B cells overexpressing Jagged-1 were capable of
reducing IFN-γ, IL-5 and IL-2 secretion from naïve T
cells, while upregulating the production of TGF-β, a sol-
uble factor associated with a Treg phenotype [39]. In
support of these findings, Asano et al. showed that both
the Notch and TGFβ signalling pathways interact to-
gether, with the blockade of the Notch signalling path-
way interfering with the suppressor effect mediated by
the production of TGF-β by Treg [51]. In addition, both
Notch-1 and TGFβ have been shown to regulate the ex-
pression of FoxP3 and the induction of a Treg popula-
tion [53]. Taken together, these findings highlighted an
important role for Notch signalling in Treg induction/
expansion further explored herein.
Notch has been previously implicated as a contact sig-
nal in immunomodulation [39,54]. The capacity of MSC
to inhibit T cell proliferation was significantly reversed
when Notch signalling was blocked through the addition
of a Notch signalling inhibitor (N-(N-(3,5-difluorophe-
nacetyl)-L-alanyl)-S-phenylglycine t-butyl ester (DAPT))
or a Jagged-1 neutralising antibody [40]. In support of
these findings, the data described here show that sup-
pression of Notch signalling by GSI resulted in a reduc-
tion of MSC driven expansion of Treg. As addition of
GSI only partially abrogated the expansion of Treg in
MSC co-cultures, we must consider the possibility that
GSI is unable to inhibit all Notch signalling as previously
discussed [55]. Furthermore, our study identified the
specific Notch ligand responsible for this effect. Utilising
Jagged-1 knock down MSC, we demonstrate that the ex-
pansion of Treg was significantly impaired. A recent
study identified Notch-1 on CD4+ cells as the principle
receptor involved in MSC recruitment of inducible Treg
(iTreg). This study utilised a GSI inhibitor and a neutralis-
ing Notch-1 antibody to demonstrate a role for Notch-1
signalling in MSC expansion of Treg in CD4+/MSC co-
cultures [37]. However, as those authors started with a
whole CD4+ T cell population (containing Foxp3+ CD4+
T cells), that study did not provide evidence for the cap-
acity of MSC to induce a population of Treg fromFoxp3− T cells. Indeed, careful analysis suggests that
these data [37] support our findings that MSC expand
but do not induce a population of Treg and that Jagged-1
expression by MSC (Figure 1) and potential Notch-1 ex-
pression by CD4+ T cells [37] facilitates MSC expansion of
Treg in vitro. Differences in cell populations and species
(human versus mouse MSC) may also account for some
of the disparities between these studies.
It is now known that MSC modulation of DC function
involves both soluble and cell contact factors [20-23,56-58].
Our data clearly confirm that MSC are capable of inhibiting
LPS-induced DC maturation and identifies an important
role for Notch signalling in MSC expansion of Treg. The
functionality of these semi-mature DC was examined fur-
ther demonstrating an ability to inhibit antigen specific T
cell proliferation in a Notch dependent manner, indicating
regulatory properties. Interestingly, the semi-mature DC
described herein were capable of Treg induction. Two
previous studies support the importance of the Notch sig-
nalling pathway in immune regulation [22,23]. Using a
GSI (DAPT), Li et al. demonstrated a key role for Notch
signalling in MSC generation of regulatory DC [23]. Simi-
lar studies carried out using siRNA techniques showed
that tDC regulation of lymphocyte proliferation was
dependent on Jagged-2 signalling [22]. Following co-
culture with MSC, the resulting tDC were found to ex-
press increased levels of Jagged-2; siRNA knock down of
this ligand resulted in abrogation of tDC inhibition of
lymphocyte proliferation [22]. Collectively, the data herein
and that of others complete the story of Notch signalling
in MSC modulation of T cells and DC. We showed that
not only do Jagged-1 expressing MSC expand a Treg
population, but in turn induce tDC which generate Treg
from a null population.
Importantly, this is the first study to demonstrate the
functional relevance for Jagged-1 signalling in MSC pro-
tection against inflammation in vivo. In agreement with
previous findings, MSC reduced allergen-induced airway
pathology and enhanced Treg [30,46,50] and IL-10 pro-
duction in the lungs and spleen, respectively. The major
advance in our understanding of MSC mechanisms of
action in vivo lies in the observation that Jagged-1 knock
down MSC failed to protect against allergic airway in-
flammation and was associated with reduced Treg in the
lungs and decreased IL-10 production by allergen re-
stimulated spleen cells. These observations have im-
portant ramifications for the Notch signalling family
as potential therapeutic targets in MSC immunomodulation.
Conclusions
In conclusion, our data demonstrated the requirement
for Jagged-1 signalling in MSC expansion of Tregs and
induction of semi mature DC in vitro. Importantly, these
semi mature DC were functional and had the capacity to
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study highlights the importance of Jagged-1 signalling in
MSC protection in vivo. Utilising a mouse model of al-
lergic airway inflammation, we show that MSC but not
Jagged-1 knock down MSC provided protection against
lung inflammation. Notably, the protective effects medi-
ated by MSC were associated with enhanced Treg in the
lung and significantly increased levels of IL-10 in spleno-
cytes and these effects were not seen in mice treated
with Jagged-1 knock down MSC. Together these findings
enhance our understanding of the mechanisms of action
used by MSC in promoting a regulatory environment
through expansion/induction of semi mature DC and
Treg. Moreover, linking in vitro data on MSC mechan-
ism of action with in vivo models provides important
pre-clinical data and informs us on how these cells may
mediate their effects in relevant clinical diseases.Additional files
Additional file 1: Figure S1. Characterisation of MSC. BALB/c and
C57BL/6 MSC were characterised for the expression of a variety of cell
surface markers against their corresponding isotypes. In total, 10,000
events were recorded for each marker (A). MSC were co-cultured with
splenocytes from BALB/c or C57BL/6 mice for 72 hours. Proliferation was
measured by [3H] thymidine uptake over a six hour period. Mitogen driven
proliferation was examined using ConA (5 ug/ml). Results are represented in
counts per minute. MSC significantly reduced the proliferation of both
allo-driven proliferation (**, P <0.01) and mitogen stimulation (***, P <0.001)
(B). MSC (5 × 104) were cultured for 21 days in control media or with
osteogenic, or adipogenic medium. Cultures were stained with Alazarin Red
and Oil Red O (C). MSC (2 × 105) were also cultured in a control medium or
chondrogenic medium for 21 days after which mRNA levels of the
chondrogenic markers aggrecan and collagen II were examined by RT-PCR
(D). Results are representative of multiple passages.
Additional file 2: Figure S2. Notch/Jagged family expression profile
and verification of Jagged 1 knockdown MSC. MSC were examined for
expression of the Notch/Jagged family mRNA by RT-PCR. Known positive
controls were used for each set of primers, Notch 1, Delta Like ligand 1
(spleen), Notch 2 (bone marrow), Jagged1 and Jagged 2 (J774) (A).
Jagged 1 shMSC were positively selected using puromycin and allowed
to reach confluence, the cells were passaged and 5 × 106 cells were
collected using trizol for mRNA analysis. RNA was isolated and cDNA
produced. The cells were examined at a protein level or Jagged 1
expression by flow cytometry (B). The cells were also tested by real
time PCR for the expression of Jagged 1 (C) and reverse transcription
PCR for Delta like ligand 1 (D) and the results compared with non-transduced
MSC, non-silencing control MSC or non-template control (NTC). Importantly,
the Jagged 1 knock down MSC and the non silencing control MSC
expressed Delta like ligand 1.
Additional file 3: Figure S3. Characterisation of Jagged 1 knockdown
MSC. BALB/c Jagged 1 knock down (J1 KD) MSC were characterised by
looking at the expression of a variety of cell surface markers against their
corresponding isotypes. In total, 10,000 events were recorded for each
marker (A). J1 KD MSC (5 × 104) were cultured for 21 days in control
medium or with osteogenic, or adipogenic medium. Cultures were
stained with Alazarin Red and Oil Red O (B). MSC (2 × 105) were cultured
in a control media or chondrogenic media for 21 days after which mRNA
levels of the chondrogenic markers aggrecan and collagen II were
examined by RT-PCR (C). Results are representative of similar findings at
multiple passage.
Additional file 4: Figure S4. MSC induce a semi mature DC
phenotype. DC (0.5 × 106/ml) matured with LPS (100 ng/ml) (mDC)displayed increased MHC class II and CD86 expression after 48 hours
detected by flow cytometry. DC matured in the presence of MSC
(1.5 × 105/ml) had decreased levels of (A) MHC class II and (B) CD86
expression, indicative of a semi-mature phenotype. Bar charts represent
mean fluoresecence intensity (MFI). Data represents three studies. (*, P <0.05)
(***, P <0.001). C57BL/6 DC pulsed with I-Eα peptide were co-cultured with
wild-type (Wt) allogeneic MSC or Jagged-1 knocked down (Jag 1KD) MSC for
48 hours. The number of DC presenting I-Eα peptide was measured using a
YAe biotin conjugated anti-I-Ab: Eα complex specific antibody. Percentages of
cells are displayed within the marked regions (C).
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